Skip to content
Screener

Solesence, Inc. SLSN Q1 2026 Annual earnings

Reported May 12, 2026 · After market close

Revenue$13.0M
EPS-$0.01

Next report

Nov 16, 2026 (in 3 months)

Financials

Q1 2026

Income statement

See full
Revenue$13.0M-11.4%
Gross profit$3.1M-7.1%
Operating income-$700.0K-373%
Net income-$962.0K-380%
EPS (diluted)-$0.01—

Balance sheet

See full
Cash & equivalents$573.0K-68.5%
Total debt$9.7M-3.3%
Total equity$13.2M+22.1%
Total assets$44.1M-22.7%

Cash flow

See full
Operating cash flow$1.5M+121%
CapEx$528.0K+497%
Free cash flow$989.0K+113%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$66.98M—
Enterprise value$76.15M—
P/E51×—
P/S1.1×—

Profitability

See full
Gross margin27.1%-0.9pp
Operating margin2%-5.9pp
Net margin2.2%—

Returns & leverage

See full
Return on equity10.9%—
Debt / equity0.7×-0.2×
Current ratio1.8×+0.7×

Segments

By product

See full
Consumer Products$10.0M-22.2%
Personal Care Ingredients$2.7M+98.5%
Advanced Materials$205.0K-44.6%

By geography

See full
Non Us$913.0K-8.1%

FAQ

When did Solesence, Inc. report Q1 2026 earnings?
Solesence, Inc. (SLSN) reported Q1 2026 earnings on May 12, 2026 after market close.
What were Solesence, Inc.'s Q1 2026 revenue and EPS?
Solesence, Inc. reported revenue of $13.0M and eps of $-0.01 for Q1 2026.
How did Solesence, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 11.4% from $14.6M a year earlier.
Where can I find Solesence, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-003273) and the 10-K periodic report (0001999371-26-007345) directly on SEC EDGAR. The filing index links above go to sec.gov.